USP37 and breast cancer: Several studies have indicated that elevated expression of USP37 in various tumors is closely associated with patient prognosis, including colorectal cancer (Wu et al., 2025) renal cancer (Hong et al., 2020), breast cancer (Cao et al., 2023; Zha et al., 2016), and gastric cancer (Wu et al., 2021).